A screening study on the detection strain of Coxsackievirus A6: the key to evaluating neutralizing antibodies in vaccines

Immunogenicity and safety of an<i> ORF7</i>-deficient skin- attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2atrial

Serological and Molecular Detection of Citrus Tristeza Virus: A Review

Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects

Therapeutic vaccine-induced plasma cell differentiation is defective in the presence of persistently high HBsAg levels

Construction and characterization of an infectious cDNA clone of human rhinovirus A89

Canonical Wnt signaling directs the generation of functional human PSC-derived atrioventricular canal cardiomyocytes in bioprinted cardiac tissues

Cytomegalovirus-vectored COVID-19 vaccines elicit neutralizing antibodies against the SARS-CoV-2 Omicron variant (BA.2) in mice

A novel recombinant ORF7-siRNA delivered by flexible nano-liposomes inhibits varicella zoster virus infection

Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies

Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD

Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters

Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial

Rationally designed synthetic vectors for therapeutic nucleic acid delivery against human cytomegalovirus infection

A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19

Transcriptomics confirm the establishment of a liver-immune dual-humanized mouse model after transplantation of a single type of human bone marrow mesenchymal stem cell

Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for <i>Escherichia coli</i>-based vaccine design

Current Methods for the Detection of Antibodies of Varicella-Zoster Virus: A Review

A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model

Antiviral Nanobiologic Therapy Remodulates Innate Immune Responses to Highly Pathogenic Coronavirus

Nasal irrigation efficiently attenuates SARS-CoV-2 Omicron infection, transmission and lung injury in the Syrian hamster model

Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine

The duration and breadth of antibody responses to 3-dose of inactivated COVID-19 vaccinations in healthy blood donors: An observational study

MOLECULAR BASIS OF HEPATIC DIFFERENTIATION OF HUMAN BONE MARROW MESENCHYMAL STEM CELL IN VIVO

Zika Virus Infection Downregulates Connexin 43, Disrupts the Cardiomyocyte Gap Junctions and Induces Heart Diseases in A129 Mice

Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters

Discovery and Optimization of Quinoline Analogues as Novel Potent Antivirals against Enterovirus D68

Development of a rapid neutralization testing system for Rhinovirus C15 based on the enzyme-linked immunospot assay

Structural basis for the synergistic neutralization of coxsackievirus B1 by a triple-antibody cocktail

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2

Baculovirus Display of Varicella-Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice

Molecular basis of hepatic differentiation of human bone marrow mesenchymal stem cell in vivo

Development of a rapid neutralization assay for the detection of neutralizing antibodies against coxsackievirus B1

PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron

Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron

Rational Design of a Skin- and Neuro-Attenuated Live Varicella Vaccine: A Review and Future Perspectives

Cross-species tropism and antigenic landscapes of SARS-CoV-2 variants

Female sex hormone, progesterone, ameliorates the severity of SARS-CoV-2-caused pneumonia in the Syrian hamster model

Development of a skin- and neuro-attenuated live vaccine for varicella

Persisting lung pathogenesis and minimum residual virus in hamster after acute COVID-19

Dexamethasone ameliorates severe pneumonia but slightly enhances viral replication in the lungs of SARS-CoV-2-infected Syrian hamsters

A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2

Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters

Gender associates with both susceptibility to infection and pathogenesis of SARS-CoV-2 in Syrian hamster

Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating

The prevalence of antibodies to SARS-CoV-2 among blood donors in China

Virus-Free and Live-Cell Visualizing SARS-CoV-2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors

SARS-CoV-2 infection and disease outcomes in non-human primate models: advances and implications

A SCID mouse-human lung xenograft model of SARS-CoV-2 infection

Near-atomic cryo-electron microscopy structures of varicella-zoster virus capsids

DLL4 restores damaged liver by enhancing hBMSC differentiation into cholangiocytes

Rapid Neutralization Testing System for Zika Virus Based on an Enzyme-Linked Immunospot Assay

Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16

A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice

Animal models for emerging coronavirus: progress and new insights

HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation

A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge

HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation

Agonist c-Met monoclonal antibody augments the proliferation of hiPSC-derived hepatocyte-like cells and improves cell transplantation therapy for liver failure in mice

Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10

A second open reading frame in human enterovirus determines viral replication in intestinal epithelial cells

Robust in vitro assay for analyzing the neutralization activity of serum specimens against hepatitis B virus

Ferritin nanocage-based antigen delivery nanoplatforms: Epitope engineering for peptide vaccine design

Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization

Development of an efficient neutralization assay for Coxsackievirus A10

Agonist c-Met Monoclonal Antibody Augments the Proliferation of hiPSC-derived Hepatocyte-Like Cells and Improves Cell Transplantation Therapy for Liver Failure in Mice

HBV Infection-Induced Liver Cirrhosis Development in Dual-Humanized Mice with Human Bone Mesenchymal Stem Cell Transplantation

Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10

Optimized HepaRG is a suitable cell source to generate the human liver chimeric mouse model for the chronic hepatitis B virus infection

ER stress regulating protein phosphatase 2A-B56 gamma, targeted by hepatitis B virus X protein, induces cell cycle arrest and apoptosis of hepatocytes

A Chimeric Humanized Mouse Model by Engrafting the Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cell for the Chronic Hepatitis B Virus Infection

Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines

Serological survey of neutralizing antibodies to eight major enteroviruses among healthy population

A bispecific broadly neutralizing antibody against enterovirus 71 and coxsackievirus A16 with therapeutic potential

Bioinspired Artificial Nanodecoys for Hepatitis B Virus

Outer nuclear membrane fusion of adjacent nuclei in varicella-zoster virus-induced syncytia

Varicella-zoster virus ORF7 interacts with ORF53 and plays a role in its trans-Golgi network localization

Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody

A neonatal mouse model of coxsackievirus A10 infection for anti-viral evaluation

Herpes simplex virus type 1 abrogates the antiviral activity of Ch25h via its virion host shutoff protein

ORF7 of Varicella-Zoster Virus Is Required for Viral Cytoplasmic Envelopment in Differentiated Neuronal Cells

A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus

A novel toolbox for the in vitro assay of hepatitis D virus infection

A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice

Evaluation of immunity to varicella zoster virus with a novel double antigen sandwich enzyme-linked immunosorbent assay

A neonatal mouse model for the evaluation of antibodies and vaccines against coxsackievirus A6

An HBV-tolerant immunocompetent model that effectively simulates chronic hepatitis B virus infection in mice

Functional Analysis of Human Cytomegalovirus UL/b ' Region Using SCID-hu Mouse Model

Development and evaluation of rapid point-of-care tests for detection of Enterovirus 71 and Coxsackievirus A16 specific immunoglublin M antibodies

Detection and analysis of tupaia hepatocytes via mAbs against tupaia serum albumin

Modulation of host CD59 expression by varicella-zoster virus in human xenografts in vivo

A highly conserved epitope-vaccine candidate against varicella-zoster virus induces neutralizing antibodies in mice

Development of sandwich ELISAs that can distinguish different types of coxsackievirus A16 viral particles

Serological Evaluation of Immunity to the Varicella-Zoster Virus Based on a Novel Competitive Enzyme-Linked Immunosorbent Assay

Extensive phagocytosis in non-viral-infected neurons observed in enterovirus A 71-infected cases

Construction and characterization of an infectious clone of coxsackievirus A6 that showed high virulence in neonatal mice

Insights into the function of tegument proteins from the varicella zoster virus

Rationally designed chemokine-based toxin targeting the viral G protein-coupled receptor US28 potently inhibits cytomegalovirus infection in vivo

A monoclonal antibody-based VZV glycoprotein E quantitative assay and its application on antigen quantitation in VZV vaccine

Analysis of Cross-Reactive Neutralizing Antibodies in Human HFMD Serum with an EV71 Pseudovirus-Based Assay

Development of a varicella-zoster virus neutralization assay using a glycoprotein K antibody enzyme-linked immunosorbent spot assay

Development of an Enzyme-Linked Immunosorbent Spot Assay To Measure Serum-Neutralizing Antibodies against Coxsackievirus B3

Protection against Lethal Enterovirus 71 Challenge in Mice by a Recombinant Vaccine Candidate Containing a Broadly Cross-Neutralizing Epitope within the VP2 EF Loop

The Cross-Neutralizing Activity of Enterovirus 71 Subgenotype C4 Vaccines in Healthy Chinese Infants and Children

Development of a novel baculovirus titration method using the Enzyme-linked immunosorbent spot (ELISPOT) assay

ORF7 of Varicella-Zoster Virus Is a Neurotropic Factor

Efficient inhibition of HIV-1 replication by an artificial polycistronic miRNA construct

RNA Interference inhibits Hepatitis B Virus of different genotypes in Vitro and in Vivo

Genome-Wide Mutagenesis Reveals That ORF7 Is a Novel VZV Skin-Tropic Factor

Performance of Detecting IgM Antibodies against Enterovirus 71 for Early Diagnosis

Tetracysteine as a Reporter for Gene Therapy

Difference of T cell and B cell activation in two homologous proteins with similar antigenicity but great distinct immunogenicity

Immune response induced by a different combined immunization of HBsAg vaccine

Variants of green fluorescent protein GFPxm

Hydrophobicity of reactive site loop of SCCA1 affects its binding to hepatitis B virus